1Turner RC, Holman RR. Lessons from UK Prospective Diabetes Study[J]. Diabetes Res Clin Pract, 1995.28: S151-157.
2UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with snlphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet, 1998, 352: 837-853.
3American Diabetes Association. Standards of medical care in diabetes[J]. Diabetes Care, 2004, 27(Suppl 1): S15 - S34.
4Global guidelines for type 2 diabetes[z].International Diabetes Federation, 2005.
5Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy[J]. Diabetes Care, 2008,31: 1-11.
6Pontiroli AE, Calderara A, Pozza G, et al. Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management[J]. Diabeted Metabolism Reviews, 1994, 10(1): 31-43.
8Slama G. Diagnosis and clinical aspects of secondary failure of oral antidiabetic agents[J]. Diahetes Research and Clinical Practice, 1988, Suppl: 3-5.
